# Core: Biorepository and Clinical Trial Office Shared Resource

> **NIH NIH U54** · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2021 · $31,213

## Abstract

BIOREPOSITORY AND CLINICAL TRIALS OFFICE SHARED RESOURCE
SUMMARY
The establishment and implementation of the South Carolina Cancer Disparities Research Center (SC
CADRE) Biorepository/Clinical Trials Office (CTO) Shared Resource is expected to significantly expand the
research capacity of the SC CADRE investigators at South Carolina State University (SCSU), thus enhancing
their ability to compete for independent, R01-level funding. This new, dual-component Shared Resource will
also augment SCSU's ability to attract additional junior faculty researchers who will have access to
biospecimens from racially and ethnically diverse patient populations as well as to clinical trials infrastructure at
the Regional Medical Center of Orangeburg Mabry Cancer Center (RMC-MCC). The overarching goal of the
Biorepository/CTO Shared Resource is to support the development of cancer research at SCSU through both
a Biorepository component and a CTO component. The Biorepository component will give SC CADRE
investigators access to the RMC-MCC's patient blood and tissue specimens that were previously unavailable
for research due to the lack of a biorepository infrastructure. Likewise, the CTO component will facilitate the
implementation of clinical trials, providing an infrastructure for SCSU investigators to conduct research in their
Orangeburg, SC community as well as providing the Orangeburg community immediate access to other NCI-
approved clinical trials which have not been available to date. This Shared Resource will support the
implementation of two initial SC CADRE clinical trials in Years 1-3 which will provide the biological and
outcomes data needed to evaluate the hypothesized relationships that are being assessed in each of the three
initial SC CADRE Full and Pilot Research Projects. Additionally, this Biorepository/CTO Shared Resource will
support future SC CADRE Full and Pilot Research Projects as well as other NCI-approved clinical research
studies at the RMC-MCC, with the goal of enhancing participation of diverse populations in cancer clinical
research.

## Key facts

- **NIH application ID:** 10246909
- **Project number:** 5U54CA210962-05
- **Recipient organization:** MEDICAL UNIVERSITY OF SOUTH CAROLINA
- **Principal Investigator:** STEVEN L. CARROLL
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $31,213
- **Award type:** 5
- **Project period:** 2017-09-21 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10246909

## Citation

> US National Institutes of Health, RePORTER application 10246909, Core: Biorepository and Clinical Trial Office Shared Resource (5U54CA210962-05). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10246909. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*